SCHEMBL3754181

SCHEMBL3754181

COc1ccc(Cl)c(Oc2nc(-c3cccc(F)c3F)ccc2C(=O)O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLG P00747 1/20 0.43
PLAU P00749 1/20 0.43
EIF4E P06730 4/20 0.42
PYGL P06737 1/20 0.42
PYGM P11217 1/20 0.42
KDM4E B2RXH2 3/20 0.41
POLB P06746 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
RORC P51449 1/20 0.39
PRKAB2 O43741 1/20 0.39
PRKAG1 P54619 1/20 0.39
PRKAA2 P54646 1/20 0.39
PRKAA1 Q13131 1/20 0.39
PRKAG3 Q9UGI9 1/20 0.39
PRKAG2 Q9UGJ0 1/20 0.39
PRKAB1 Q9Y478 1/20 0.39
LMNA P02545 1/20 0.38
PDCD1LG2 Q9BQ51 1/20 0.38
CD274 Q9NZQ7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3762159 0.92 KDM4E (0.42) PLGPLAUEIF4EPYGLPYGM
SCHEMBL3750445 0.88 EIF4E (0.43) PLGPLAUEIF4EKDM4ECD274
SCHEMBL3755130 0.85 KMO (0.44) EIF4EKDM4EPDCD1LG2CD274KMO
SCHEMBL3758381 0.85 MRGPRX4 (0.42) EIF4EKDM4E
SCHEMBL3347867 0.83 NPC1 (0.42) PLGPLAUEIF4EPYGLPYGM
SCHEMBL3747290 0.83 ALDH1A1 (0.40) KDM4EMEN1KMT2ALMNAPDCD1LG2
SCHEMBL3759586 0.82 HTT (0.47) KDM4EPDCD1LG2CD274
SCHEMBL3757989 0.82 MRGPRX4 (0.41) EIF4EAKR1C2
SCHEMBL3753505 0.81 ALDH1A1 (0.43) PLGPLAUEIF4EKDM4ECD274
SCHEMBL8202342 0.80 EIF4E (0.41) PLGPLAUEIF4EPYGLPYGM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298221-A1 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-11-25 US disclosed
US-20100298221-A1 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-11-25 US disclosed
US-20100298221-A1 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298221-A1 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF NAPRT, PNPO, FABP3 PLG 436/4885PLAU 1022/4885EIF4E 3817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.